SeekingAlpha · Nov 10, 2026
NU
NYSE · NUS
Nu Skin Enterprises, Inc.
Consumer Defensive · Household & Personal Products
$4.01
Up+$0.12 (+3.08%)
Updated Nov 13, 2026, 11:48 AM
SID Score
2.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 518.35M
- P/E ratio
- 4.71
- Dividend yield
- 5.99%
- 52-week range
- $3.87 – $8.08
- Volume
- 673.44K
- Avg. volume
- 507.91K
Price performance · NUS
NUS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 12, 2026
NUS closed at $4.01 after 21 trading sessions, down 23.03% for the selected period.
- Last close
- $4.01
- Period change
- -23.03%
- Period low
- $3.89
- Period high
- $5.21
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | $3.88 | $4.03 | $3.87 | $4.01 | 673.44K |
| Nov 11, 2026 | $4.02 | $4.109 | $3.88 | $3.89 | 697.06K |
| Nov 10, 2026 | $4.27 | $4.27 | $4.02 | $4.03 | 566.78K |
| Nov 9, 2026 | $4.12 | $4.41 | $3.995 | $4.28 | 1.14M |
| Nov 6, 2026 | $4.31 | $4.61 | $4.09 | $4.10 | 896.36K |
| Nov 5, 2026 | $5.09 | $5.15 | $4.485 | $4.53 | 723.76K |
| Nov 4, 2026 | $4.83 | $5.13 | $4.83 | $4.99 | 646.14K |
| Nov 3, 2026 | $4.83 | $4.87 | $4.68 | $4.70 | 435.85K |
| Nov 2, 2026 | $4.71 | $4.8499 | $4.71 | $4.78 | 637.83K |
| Oct 30, 2026 | $4.71 | $4.80 | $4.625 | $4.65 | 351.49K |
| Oct 29, 2026 | $4.83 | $4.86 | $4.68 | $4.69 | 253.03K |
| Oct 28, 2026 | $4.66 | $4.81 | $4.649 | $4.76 | 476.98K |
| Oct 27, 2026 | $4.72 | $4.76 | $4.61 | $4.73 | 533.93K |
| Oct 26, 2026 | $4.80 | $4.83 | $4.665 | $4.69 | 477.13K |
| Oct 23, 2026 | $4.86 | $4.895 | $4.7178 | $4.79 | 318.24K |
| Oct 22, 2026 | $4.86 | $4.97 | $4.70 | $4.92 | 271.3K |
| Oct 21, 2026 | $4.99 | $4.995 | $4.76 | $4.76 | 422.19K |
| Oct 20, 2026 | $5.02 | $5.08 | $4.97 | $4.98 | 327.61K |
| Oct 19, 2026 | $5.12 | $5.15 | $4.96 | $4.97 | 323.57K |
| Oct 16, 2026 | $5.24 | $5.39 | $5.11 | $5.14 | 572.31K |
| Oct 15, 2026 | $5.16 | $5.335 | $5.16 | $5.21 | 511.36K |
Latest NUS news
The latest Smart Investors Daily articles mentioning NUS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
NUS research
Overview
Company profile and research snapshot.
Company profile
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $11.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Dec 20, 2024 | DA Davidson | Neutral | — |
| Oct 22, 2024 | Citigroup | Neutral | — |
| Aug 12, 2024 | DA Davidson | Neutral | — |
| Aug 9, 2024 | Citigroup | Neutral | — |
| May 9, 2024 | DA Davidson | Neutral | — |
News briefing
No generated briefing is available yet.
Yahoo · Nov 9, 2026
Nu Skin Enterprises Inc (NUS) (Q3 2026) Earnings Call Highlights: Prism Momentum and RISE ...
Nu Skin Enterprises Inc (NUS) posted in-line Q3 results as Prism.io conversion doubled and RISE manufacturing surged, though gross margin and core customer metrics remained under pressure.
Yahoo · Nov 8, 2026
What Nu Skin Enterprises (NUS) Said on Its Q3 Earnings Call
Nu Skin Enterprises (NYSE:NUS) reported third-quarter 2026 revenue of $311 million and adjusted earnings of $0.10 per share, both within its guidance ranges, as growth in its Rhyz manufacturing business helped offset pressure in its core operations. The company reported a loss of $0.02 per share un
SeekingAlpha · Nov 6, 2026
Nu Skin Enterprises, Inc. (NUS) Q3 2026 Earnings Call Transcript
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
